RAPT Therapeutics Correlations

RAPT Stock

USD 1.31 0.11 9.17%

The current 90-days correlation between RAPT Therapeutics and Molecular Partners AG is 0.24 (i.e., Modest diversification). The correlation of RAPT Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

RAPT Therapeutics Correlation With Market

Modest diversification

The correlation between RAPT Therapeutics and DJI is 0.22 (i.e., Modest diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding RAPT Therapeutics and DJI in the same portfolio, assuming nothing else is changed.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RAPT Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

For more information on how to buy RAPT Stock please use our How to Invest in RAPT Therapeutics guide.

Moving together with RAPT Stock

0.67

MDAI

Spectral AI

Pair Corr

Moving against RAPT Stock

0.37	NVRO	Nevro Corp	Pair Corr
0.32	INMD	InMode	Pair Corr
0.57	SWZNF	Schweizerische Nationalbank	Pair Corr

Related Correlations Analysis

	CNTB	TYRA	XLO	MLYS	MOLN	ANTX	PHVS	PEPG	GLUE	DSGN
CNTB		0.75	0.27	-0.14	0.56	0.29	0.73	0.5	0.28	0.47	CNTB
TYRA	0.75		0.33	-0.32	0.8	0.14	0.72	0.34	0.03	0.35	TYRA
XLO	0.27	0.33		-0.15	0.33	0.07	0.2	0.32	0.05	0.21	XLO
MLYS	-0.14	-0.32	-0.15		-0.59	0.78	-0.03	0.32	0.43	0.37	MLYS
MOLN	0.56	0.8	0.33	-0.59		-0.16	0.54	0.3	-0.07	0.21	MOLN
ANTX	0.29	0.14	0.07	0.78	-0.16		0.26	0.67	0.38	0.6	ANTX
PHVS	0.73	0.72	0.2	-0.03	0.54	0.26		0.42	0.37	0.54	PHVS
PEPG	0.5	0.34	0.32	0.32	0.3	0.67	0.42		0.43	0.81	PEPG
GLUE	0.28	0.03	0.05	0.43	-0.07	0.38	0.37	0.43		0.55	GLUE
DSGN	0.47	0.35	0.21	0.37	0.21	0.6	0.54	0.81	0.55		DSGN
	CNTB	TYRA	XLO	MLYS	MOLN	ANTX	PHVS	PEPG	GLUE	DSGN

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Please upgrade your account to get full access to Macroaxis premium features

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

DSGN	+ 0.81	PEPG
MOLN	+ 0.8	TYRA
ANTX	+ 0.78	MLYS
TYRA	+ 0.75	CNTB
PHVS	+ 0.73	CNTB
PHVS	+ 0.72	TYRA

High negative correlations

MOLN	- 0.59	MLYS
MLYS	- 0.32	TYRA
ANTX	- 0.16	MOLN
MLYS	- 0.15	XLO
MLYS	- 0.14	CNTB
GLUE	- 0.07	MOLN

Risk-Adjusted Indicators

There is a big difference between RAPT Stock performing well and RAPT Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze RAPT Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
CNTB	3.51	(0.29)	0.00	(0.33)	0.00	0.00	7.59	(7.07)	29.84
TYRA	2.57	(0.39)	0.00	(0.46)	0.00	0.00	7.08	(4.82)	15.45
XLO	7.46	0.69	0.08	0.35	7.52	(12.31)	11.46	(12.84)	137.08
MLYS	4.29	0.63	0.17	(0.45)	4.26	(4.97)	10.04	(8.23)	50.53
MOLN	2.72	(0.28)	0.00	(0.21)	0.00	0.00	7.84	(7.39)	20.58
ANTX	2.41	0.03	0.03	0.07	2.54	(2.98)	5.41	(4.07)	17.09
PHVS	2.21	(0.24)	0.00	3.05	0.00	0.00	5.21	(3.86)	14.29
PEPG	8.31	(0.45)	0.00	(0.22)	0.00	0.00	19.62	(13.91)	92.48
GLUE	3.56	(0.22)	0.00	(0.26)	0.00	0.00	7.34	(7.69)	19.92
DSGN	4.21	(0.08)	0.00	(0.18)	0.00	0.00	9.45	(9.07)	26.51

RAPT Therapeutics Corporate Management

Gwen Carscadden	Chief Officer	Profile
Rodney Young	Principal CFO	Profile
David Wustrow	Senior Development	Profile
William Ho	Chief Officer	Profile
Jennifer Nicholson	Senior Assurance	Profile
Michael Listgarten	General Counsel	Profile
William MD	Chief Officer	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC